Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.58%23.06B | -6.39%6.24B | 31.09%6.73B | 3.46%4.7B | 49.31%5.4B | -3.88%19.95B | -3.80%6.66B | -11.44%5.13B | 17.56%4.54B | -13.35%3.61B |
| Net income from continuing operations | 1.60%20.06B | -4.29%5.09B | 8.21%5.27B | -1.84%4.58B | 4.68%5.12B | 14.30%19.74B | 13.61%5.32B | 17.23%4.87B | 9.54%4.66B | 17.01%4.89B |
| Operating gains losses | -7.45%87M | -200.00%-46M | 59.09%35M | -23.33%23M | 1,975.00%75M | -9.62%94M | 757.14%46M | 125.88%22M | -66.67%30M | -103.77%-4M |
| Depreciation and amortization | 17.99%1.22B | 15.33%316M | 20.08%317M | 22.49%305M | 14.17%282M | 9.65%1.03B | 10.93%274M | 12.34%264M | 6.41%249M | 8.81%247M |
| Remuneration paid in stock | 5.53%897M | 1.60%191M | 5.69%223M | 7.02%259M | 7.18%224M | 11.11%850M | 8.05%188M | 10.47%211M | 8.52%242M | 18.08%209M |
| Deferred tax | 252.00%152M | -19,400.00%-195M | 1,496.77%433M | 2.36%-124M | -35.59%38M | 79.30%-100M | 99.57%-1M | 68.69%-31M | -477.27%-127M | 144.70%59M |
| Other non cashItems | 14.94%15.82B | 19.00%4.27B | 11.36%3.98B | 14.63%3.75B | 14.72%3.83B | 13.03%13.76B | 7.17%3.59B | 12.50%3.57B | 12.61%3.27B | 21.18%3.34B |
| Change In working capital | 1.68%-15.17B | -23.23%-3.38B | 6.57%-3.53B | -8.03%-4.09B | 18.63%-4.17B | -53.98%-15.43B | -114.03%-2.75B | -112.55%-3.78B | 0.97%-3.79B | -63.22%-5.12B |
| -Change in receivables | 93.03%-168M | 116.46%377M | -144.19%-521M | 27.33%-617M | 231.19%593M | -488.29%-2.41B | -1,298.95%-2.29B | 273.13%1.18B | -537.63%-849M | -296.49%-452M |
| -Change in payables and accrued expense | -87.96%150M | -96.33%122M | 137.14%673M | -24.21%457M | -27.40%-1.1B | -12.62%1.25B | 153.44%3.32B | -216.15%-1.81B | 160.12%603M | -96.15%-865M |
| -Change in other current assets | 180.40%160M | 784.62%178M | 349.41%382M | -622.22%-390M | 95.10%-10M | -729.17%-199M | -161.90%-26M | 672.73%85M | 77.22%-54M | -227.50%-204M |
| -Change in other working capital | -8.86%-15.31B | -8.29%-4.06B | -25.83%-4.06B | -1.55%-3.54B | -1.33%-3.65B | -27.72%-14.07B | -32.70%-3.75B | -21.07%-3.23B | -25.52%-3.49B | -31.28%-3.6B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.58%23.06B | -6.39%6.24B | 31.09%6.73B | 3.46%4.7B | 49.31%5.4B | -3.88%19.95B | -3.80%6.66B | -11.44%5.13B | 17.56%4.54B | -13.35%3.61B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 136.76%708M | -47.95%304M | -146.13%-256M | 88.95%-130M | 141.82%790M | 3.99%-1.93B | 149.16%584M | 3,164.71%555M | -261.85%-1.18B | -270.39%-1.89B |
| Net PPE purchase and sale | -17.90%-1.48B | -25.89%-389M | -5.25%-421M | -16.37%-327M | -29.21%-345M | -18.70%-1.26B | -1.31%-309M | -35.59%-400M | -33.81%-281M | -7.23%-267M |
| Net business purchase and sale | 3.06%-887M | --0 | --0 | 102.08%19M | ---906M | ---915M | --0 | --0 | ---915M | --0 |
| Net investment purchase and sale | 771.98%2.96B | -43.42%529M | -80.92%183M | 235.48%208M | 225.91%2.04B | 136.77%339M | 211.84%935M | 210.36%959M | 167.39%62M | -433.66%-1.62B |
| Net other investing changes | 230.11%121M | 490.48%164M | -350.00%-18M | 28.57%-30M | 200.00%5M | -272.00%-93M | 10.64%-42M | -233.33%-4M | -82.61%-42M | -111.90%-5M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 136.76%708M | -47.95%304M | -146.13%-256M | 88.95%-130M | 141.82%790M | 3.99%-1.93B | 149.16%584M | 3,164.71%555M | -261.85%-1.18B | -270.39%-1.89B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 8.09%-18.96B | 15.12%-6B | 65.58%-1.83B | -46.10%-5.66B | -25.03%-5.48B | -16.10%-20.63B | -54.34%-7.07B | -35.52%-5.31B | -32.40%-3.87B | 31.01%-4.38B |
| Net issuance payments of debt | --3.92B | --0 | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | -9.59%-18.32B | 15.75%-4.93B | -5.63%-4.78B | -66.64%-4.6B | -12.04%-4.01B | -38.11%-16.71B | -55.91%-5.85B | -48.87%-4.53B | -25.71%-2.76B | -14.93%-3.58B |
| Cash dividends paid | -9.89%-4.63B | -10.09%-1.15B | -9.28%-1.15B | -9.81%-1.16B | -10.38%-1.17B | -12.42%-4.22B | -12.18%-1.04B | -12.70%-1.06B | -12.65%-1.06B | -12.17%-1.06B |
| Proceeds from stock option exercised by employees | 18.21%396M | 20.23%309M | -51.43%-159M | 50.63%119M | 22.12%127M | 28.85%335M | 31.12%257M | -264.06%-105M | 41.07%79M | 285.71%104M |
| Net other financing activities | -776.32%-333M | 46.00%-236M | -9.02%343M | 85.93%-19M | -368.15%-421M | -154.29%-38M | -350.52%-437M | 7,640.00%377M | -188.24%-135M | 726.32%157M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 8.09%-18.96B | 15.12%-6B | 65.58%-1.83B | -46.10%-5.66B | -25.03%-5.48B | -16.10%-20.63B | -54.34%-7.07B | -35.52%-5.31B | -32.40%-3.87B | 31.01%-4.38B |
| Net cash flow | ||||||||||
| Beginning cash position | -10.13%19.76B | 26.79%24.44B | 0.99%19.14B | 1.68%19.97B | -10.13%19.76B | 7.92%21.99B | -8.38%19.28B | -0.94%18.95B | 6.82%19.64B | 7.92%21.99B |
| Current changes in cash | 284.13%4.8B | 202.79%542M | 1,129.10%4.65B | -113.87%-1.1B | 126.79%711M | -367.04%-2.61B | -84.56%179M | -80.05%378M | -184.07%-512M | 1.19%-2.65B |
| Effect of exchange rate changes | 9.95%420M | -98.70%4M | 1,418.00%659M | 250.57%265M | -269.33%-508M | -39.94%382M | 248.08%308M | -412.50%-50M | -229.41%-176M | -56.65%300M |
| End cash Position | 26.43%24.99B | 26.43%24.99B | 26.79%24.44B | 0.99%19.14B | 1.68%19.97B | -10.13%19.76B | -10.13%19.76B | -8.38%19.28B | -0.94%18.95B | 6.82%19.64B |
| Free cash from | 15.43%21.58B | -7.96%5.85B | 33.27%6.31B | 2.61%4.37B | 50.91%5.05B | -5.09%18.69B | -4.03%6.36B | -13.96%4.73B | 16.63%4.26B | -14.66%3.35B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.